Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-20-000009

Options or other derivatives

  • Director acquired 2,007 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hacksell Uli · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +2,007 $2.48 2030-03-31 2,007 2,007 D
Loading xslF345X03/primary_doc.xml…